Celltrion

Celltrion is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Celltrion products.

Drugs from Celltrion supported via NPP

BrandGenericCategoryIndication
Oziltusdenosumab-mobzOncology Supportive (Biosimilar)Prevention of skeletal-related events in MM / bone mets; giant cell tumor of bone; hypercalcemia of malignancy

How NPP access to Celltrion products works

Reserve Meds sources Celltrion products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.

Not affiliated with Celltrion

Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Celltrion.

Start a request

Start a request for a Celltrion product

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's AI clinical and regulatory review agents. A US-licensed human pharmacist (sourced through Altima Care, a US-licensed specialty wholesaler) reviews every prescription before dispensing. Regulatory posture is AI-summarized and not legal advice; case-specific questions route to retained outside counsel. Last medically reviewed: .
WhatsApp